CoJourney Inc.
Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
Platform Provider
Program data pending ClinicalTrials.gov matching
· Last scored 2026-06-30
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
○ MHRA GMP
Quick Facts: CoJourney Inc.
- Signal Score
- 60.0/100 (as of 2026-06-30)
- Quality Compliance
- Assessment pending
- Headquarters
- Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
- Founded
- 2018
- Modalities
- Plasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About CoJourney Inc.
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesPlasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (8 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Capacity status: Limited
StatusLimited
Broad modality coverage (8 modalities)
Recent Press2 articles
Broad modality coverage (8 modalities)
Recent News 2 articles
Exegenesis Bio Announces FDA Clearance of Investigational New Drug (IND) Application for EXG102-031; A Novel Gene Therapy for the Treatment of neovascular Age-Related Macular Degeneration (nAMD) - Business Wire
CoJourney raises $30M to expand operations in Montgomery County - The Business Journals
Frequently Asked Questions About CoJourney Inc.
What is CoJourney Inc.'s CDMO Signal Score?
CoJourney Inc. has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating CoJourney Inc. for a manufacturing program?
Use the free AI matchmaker to compare CoJourney Inc. against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Porton Advanced
Cranbury, NJ (US HQ); GMP manufacturing sites in Suzhou, China
Lentiviral Vector, AAV, Adenoviral Vector, Plasmid DNA, CAR-T, TCR-T, CAR-NK, HSC, Exosome, mRNA
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.1
AAV, Lentiviral, Plasmid DNA, Adenoviral
3P Biopharmaceuticals (now 3PBIOVIAN)
Pamplona-Noáin, Spain
Biologics (microbial & mammalian), AAV, Adenoviral, Lentiviral, Cell Therapy, Plasmid DNA, Recombinant Proteins, Biosimilars, Fill/Finish (recombinant proteins & viral vectors)
Rose BioSolutions
Rockville, MD
Plasmid DNA, AAV, Lentiviral, Adenoviral, CAR-T, Cell Therapy, Gene Editing, Cell Solutions / Starting Materials
SK pharmteco
Corbeil-Essonnes, FR · King of Prussia, PA
Cell Therapy, AAV, Lentiviral, Plasmid DNA